Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis


Phase 2 Results N/A

Summary of Purpose

The study aims to determine whether tissue kallikrein (TK) is efficacy for preventing the long-term in-stent restenosis (ISR) after stenting of symptomatic atherosclerotic stenosis of the middle cerebral artery (MCA) M1 segment

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 September 2013.

1 Dec 2011 14 Dec 2011 1 Dec 2013 1 Dec 2013 1 Sep 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Investigator)
  • Purpose: Prevention
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment